// November 13, 2020
Breeding a superbug: how poor-quality medicines fuel AMR
Another public health crisis looms in the wake of the COVID-19 pandemic.
Another public health crisis looms in the wake of the COVID-19 pandemic.
To those in the pharmaceutical industry, USP may be both familiar and a little myster
Innovations in biotherapeutic medicines are advancing at an unprecedented pace and offer great pr
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis